Allegro Ophthalmics, LLC Employee Directory
Pharmaceutical ManufacturingCalifornia, United States2-10 Employees
Allegro Ophthalmics, LLC is a small biopharmaceutical company focused on developing therapies for retinal diseases. Its lead investigational drug, risuteganib (Luminate), is described as a broad-spectrum integrin inhibitor that targets oxidative stress at its source and potentially influences multiple pathways implicated in conditions such as diabetic macular edema and dry AMD. The firm positions itself as a late-stage player in the ophthalmic field, pursuing approaches intended to redefine treatment for retinal disorders. Headquartered in San Juan Capistrano, California, Allegro operates within the pharmaceutical sector with an emphasis on ophthalmic therapies. Recent activity includes participation in the 2025 Animal Health Europe Conference, where the company was recognized with the Companion Animals Prize, indicating broader engagement and visibility.